| KNECHT, H., Tomáš REIGL, M. KOTROVA, F. APPELT, P. STEWART, Vojtěch BYSTRÝ, Adam KREJČÍ, A. GRIONI, Karol PÁL, Kamila STRÁNSKÁ, Karla PLEVOVÁ, J. RIJNTJES, S. SONGIA, M. SVATON, E. FRONKOVA, J. BARTRAM, B. SCHEIJEN, D. HERRMANN, R. GARCIA-SANZ, J. HANCOCK, J. MOPPETT, J.J.M. VAN DONGEN, G. CAZZANIGA, F. DAVI, P.J.T.A. GROENEN, M. HUMMEL, E.A. MACINTYRE, K. STAMATOPOULOS, J. TRKA, A.W. LANGERAK, D. GONZALEZ, C. POTT, M. BRUGGEMANN a Nikos DARZENTAS. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. Leukemia. London: Nature Publishing Group, 2019, roč. 33, č. 9, s. 2254-2265. ISSN 0887-6924. Dostupné z: https://dx.doi.org/10.1038/s41375-019-0499-4. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1569017,
author = {Knecht, H. and Reigl, Tomáš and Kotrova, M. and Appelt, F. and Stewart, P. and Bystrý, Vojtěch and Krejčí, Adam and Grioni, A. and Pál, Karol and Stránská, Kamila and Plevová, Karla and Rijntjes, J. and Songia, S. and Svaton, M. and Fronkova, E. and Bartram, J. and Scheijen, B. and Herrmann, D. and GarciaandSanz, R. and Hancock, J. and Moppett, J. and van Dongen, J.J.M. and Cazzaniga, G. and Davi, F. and Groenen, P.J.T.A. and Hummel, M. and Macintyre, E.A. and Stamatopoulos, K. and Trka, J. and Langerak, A.W. and Gonzalez, D. and Pott, C. and Bruggemann, M. and Darzentas, Nikos},
article_location = {London},
article_number = {9},
doi = {http://dx.doi.org/10.1038/s41375-019-0499-4},
keywords = {MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL LYMPHOMA; IMMUNOGLOBULIN; PCR; STANDARDIZATION; PRIMERS; RELAPSE; RISK},
language = {eng},
issn = {0887-6924},
journal = {Leukemia},
title = {Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS},
url = {https://www.nature.com/articles/s41375-019-0499-4.pdf},
volume = {33},
year = {2019}
}
TY - JOUR
ID - 1569017
AU - Knecht, H. - Reigl, Tomáš - Kotrova, M. - Appelt, F. - Stewart, P. - Bystrý, Vojtěch - Krejčí, Adam - Grioni, A. - Pál, Karol - Stránská, Kamila - Plevová, Karla - Rijntjes, J. - Songia, S. - Svaton, M. - Fronkova, E. - Bartram, J. - Scheijen, B. - Herrmann, D. - Garcia-Sanz, R. - Hancock, J. - Moppett, J. - van Dongen, J.J.M. - Cazzaniga, G. - Davi, F. - Groenen, P.J.T.A. - Hummel, M. - Macintyre, E.A. - Stamatopoulos, K. - Trka, J. - Langerak, A.W. - Gonzalez, D. - Pott, C. - Bruggemann, M. - Darzentas, Nikos
PY - 2019
TI - Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
JF - Leukemia
VL - 33
IS - 9
SP - 2254-2265
EP - 2254-2265
PB - Nature Publishing Group
SN - 08876924
KW - MINIMAL RESIDUAL DISEASE
KW - ACUTE LYMPHOBLASTIC-LEUKEMIA
KW - CELL LYMPHOMA
KW - IMMUNOGLOBULIN
KW - PCR
KW - STANDARDIZATION
KW - PRIMERS
KW - RELAPSE
KW - RISK
UR - https://www.nature.com/articles/s41375-019-0499-4.pdf
L2 - https://www.nature.com/articles/s41375-019-0499-4.pdf
N2 - Assessment of clonality, marker identification and measurement of minimal residual disease (MRD) of immunoglobulin (IG) and T cell receptor (TR) gene rearrangements in lymphoid neoplasms using next-generation sequencing (NGS) is currently under intensive development for use in clinical diagnostics. So far, however, there is a lack of suitable quality control (QC) options with regard to standardisation and quality metrics to ensure robust clinical application of such approaches. The EuroClonality-NGS Working Group has therefore established two types of QCs to accompany the NGS-based IG/TR assays. First, a central polytarget QC (cPT-QC) is used to monitor the primer performance of each of the EuroClonality multiplex NGS assays; second, a standardised human cell line-based DNA control is spiked into each patient DNA sample to work as a central in-tube QC and calibrator for MRD quantification (cIT-QC). Having integrated those two reference standards in the ARResT/Interrogate bioinformatic platform, EuroClonality-NGS provides a complete protocol for standardised IG/TR gene rearrangement analysis by NGS with high reproducibility, accuracy and precision for valid marker identification and quantification in diagnostics of lymphoid malignancies.
ER -
KNECHT, H., Tomáš REIGL, M. KOTROVA, F. APPELT, P. STEWART, Vojtěch BYSTRÝ, Adam KREJČÍ, A. GRIONI, Karol PÁL, Kamila STRÁNSKÁ, Karla PLEVOVÁ, J. RIJNTJES, S. SONGIA, M. SVATON, E. FRONKOVA, J. BARTRAM, B. SCHEIJEN, D. HERRMANN, R. GARCIA-SANZ, J. HANCOCK, J. MOPPETT, J.J.M. VAN DONGEN, G. CAZZANIGA, F. DAVI, P.J.T.A. GROENEN, M. HUMMEL, E.A. MACINTYRE, K. STAMATOPOULOS, J. TRKA, A.W. LANGERAK, D. GONZALEZ, C. POTT, M. BRUGGEMANN a Nikos DARZENTAS. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. \textit{Leukemia}. London: Nature Publishing Group, 2019, roč.~33, č.~9, s.~2254-2265. ISSN~0887-6924. Dostupné z: https://dx.doi.org/10.1038/s41375-019-0499-4.
|
